Experiment 326366

Worktypes

PHARMACEUTICAL FORMULATION OFEFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBED

Compounds isolated

ERGOCORNINEERGOCRYPTINE,ALPHA: 2-BROMO:*DOPA,L:ERGONORCORNINE,9-10-DIHYDRO:

Details

PropertyValue
Pharmacology
ANTIBACTERIAL ACTIVITY
Administration routeORAL
OrganismEmpty organism
CitationRICHARDSON,BP:. (1974). PHARMACEUTICAL COMPOSITIONS CONTAINING ERGOT ALKALOIDS.. ()
Amount utilized
Compound isolated
DiseaseCHRONIC KIDNEY INFECTION
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT